NCT00149669View on ClinicalTrials.gov

Employment-based Reinforcement of Naltrexone Ingestion and Abstinence

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Cocaine-Related DisordersHeroin DependenceOpioid-Related DisordersSubstance Abuse, Intravenous
Interventions
BEHAVIORAL

employment-based reinforcement

Work Plus Naltrexone Contingency participants were required to ingest naltrexone to work, and received a brief pay decrease for missing a dose.

Trial Locations (1)

21224

The Center for Learning and Health, Baltimore

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Johns Hopkins University

OTHER

NCT00149669 - Employment-based Reinforcement of Naltrexone Ingestion and Abstinence | Biotech Hunter | Biotech Hunter